[1]
|
中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版) [J]. 中国癌症杂志, 2021, 31(6): 474-489.
|
[2]
|
Nayar, R. and Solomon, D. (2004) Second Edition of ‘The Bethesda System for Reporting Cervical Cytology’ Atlas, Website, and Bethesda Interobserver Reproducibility Project. CytoJournal, 1, Article 4. https://doi.org/10.1186/1742-6413-1-4
|
[3]
|
Possati-Resende, J.C., Fregnani, J., Kerr, L.M., et al. (2015) The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL. PLOS ONE, 10, e0134445. https://doi.org/10.1371/journal.pone.0134445
|
[4]
|
Wang, Z., Gu, Y., Wang, H., et al. (2020) Distribution of Cervical Lesions in High-Risk HPV (hr-HPV) Positive Women with ASC-US: A Retrospective Single-Center Study in China. Virology Journal, 17, Article No. 185. https://doi.org/10.1186/s12985-020-01455-2
|
[5]
|
黄太胜, 候丛哲, 朱琳, 等. PAX1甲基化检测在非典型鳞状细胞分流中的临床应用研究[J]. 中国实用妇科与产科杂志, 2022, 38(8): 847-850.
|
[6]
|
Schiffman, M., Vaughan, L.M., Raine-Bennett, T.R., et al. (2015) A Study of HPV Typing for the Management of HPV-Positive ASC-US Cervical Cytologic Results. Gynecologic Oncology, 183, 573-578. https://doi.org/10.1016/j.ygyno.2015.06.040
|
[7]
|
Tao, X., Austin, R.M., Yu, T., et al. (2022) Risk Stratification for Cervical Neoplasia Using Extended High-Risk HPV Genotyping in Women with ASC-US Cytology: A Large Retrospective Study from China. Cancer Cytopathology, 130, 248-258. https://doi.org/10.1002/cncy.22536
|
[8]
|
Wang, W., Zhang, H., Lin, L., et al. (2021) Efficient Combination of Human Papillomavirus Genotyping for the Triage of Women with Atypical Squamous Cells of Undetermined Significance in Chinese Rural Population: A Population-Based Study. Journal of Cancer, 12, 2815-2824. https://doi.org/10.7150/jca.55771
|
[9]
|
Zhang, J., Cheng, K. and Wang, Z. (2020) Prevalence and Distribution of Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia in China: A Meta-Analysis. Archives of Gynecology and Obstetrics, 302, 1329-1337. https://doi.org/10.1007/s00404-020-05787-w
|
[10]
|
Petry, K.U., Liebrich, C., Luyten, A., et al. (2017) Surgical Staging Identified False HPV-Negative Cases in a Large Series of Invasive Cervical Cancers. Papillomavirus Research, 4, 85-89. https://doi.org/10.1016/j.pvr.2017.10.003
|
[11]
|
效小莉, 付凤仙, 宋紫晖, 等. 高危型HPV分型检测作为ASCUS分流管理手段的探讨[J]. 中国妇幼保健, 2019, 34(13): 2946-2949.
|
[12]
|
吴玉梅, 王建东, 张师前, 等. 老年女性子宫颈病变筛查及异常管理中国专家共识(2023年版) [J]. 中国实用妇科与产科杂志, 2023, 39(5): 531-536.
|
[13]
|
李小芳, 姜汉国, 陈永华, 等. DNA定量分析及HPV检测在意义不明的非典型鳞状细胞患者分流中的意义[J]. 广东医学院学报, 2015, 33(5): 558-561.
|
[14]
|
张敦兰, 阳艳, 周利敏. DNA倍体分析在ASCUS分流诊断中的意义[J]. 中华妇产科杂志, 2012, 47(4): 259-262.
|
[15]
|
潘银燕, 李世宏, 苏士忠, 等. 液基细胞学、HPV检测及DNA倍体定量分析在宫颈癌筛查中的价值[J]. 中国妇产科临床杂志, 2023, 24(1): 69-70.
|
[16]
|
马希, 郝敏. p16、Ki67及FRα预测低度宫颈上皮内瘤变转归的研究进展[J]. 现代肿瘤医学, 2020, 28(12): 2168-2172.
|
[17]
|
Yu, L., Fei, L., Liu, X., et al. (2019) Application of p16/Ki-67 Dual-Staining Cytology in Cervical Cancers. Journal of Cancer, 10, 2654-2660. https://doi.org/10.7150/jca.32743
|
[18]
|
Han, Q., Guo, H., Geng, L., et al. (2020) p16/Ki-67 Dual-Stained Cytology Used for Triage in Cervical Cancer Opportunistic Screening. Chinese Journal of Cancer Research, 32, 208-217. https://doi.org/10.21147/j.issn.1000-9604.2020.02.08
|
[19]
|
Uijterwaal, M.H., Witte, B.I., Van Kemenade, F.J., et al. (2014) Triaging Borderline/Mild Dyskaryotic Pap Cytology with p16/Ki-67 Dual-Stained Cytology Testing: Cross-Sectional and Longitudinal Outcome Study. British Journal of Cancer, 110, 1579-1586. https://doi.org/10.1038/bjc.2014.34
|
[20]
|
Wentzensen, N., Fetterman, B., Castle, P.E., et al. (2015) p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women. Journal of the National Cancer Institute, 107, 257-265. https://doi.org/10.1093/jnci/djv257
|
[21]
|
Dawson, M.A. and Kouzarides, T. (2012) Cancer Epigenetics: From Mechanism to Therapy. Cell, 150, 12-27. https://doi.org/10.1016/j.cell.2012.06.013
|
[22]
|
Thompson, B., Davidson, E.A., Liu, W., et al. (2021) Overview of PAX Gene Family: Analysis of Human Tissue-Specific Variant Expression and Involvement in Human Disease. Human Genetics, 140, 381-400. https://doi.org/10.1007/s00439-020-02212-9
|
[23]
|
Pun, P.B., Liao, Y.-P., Su, P.-H., et al. (2015) Triage of High-Risk Human Papillomavirus-Positive Women by Methylated POU4F3. Clinical Epigenetics, 7, 85-93. https://doi.org/10.1186/s13148-015-0122-0
|
[24]
|
梁婷婷, 王华丽, 朱琳, 等. PAX1基因甲基化与宫颈高级别上皮内病变及高危型HPV分型的关联性[J]. 山东大学学报, 2015, 59(11): 48-52.
|
[25]
|
Liu, H., Meng, X. and Wang, J. (2020) Real Time Quantitative Methylation Detection of PAX1 Gene in Cervical Cancer Screening. International Journal of Gynecological Cancer, 30, 1488-1492. https://doi.org/10.1136/ijgc-2019-001144
|
[26]
|
Li, S.R., Wang, Z.M., Wang, Y.H., et al. (2015) Value of PAX1 Methylation Analysis by MS-HRM in the Triage of Atypical Squamous Cells of Undetermined Significance. Asian Pacific Journal of Cancer Prevention, 16, 5843-5846. https://doi.org/10.7314/APJCP.2015.16.14.5843
|